The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Signed on May 12, the order aims to enforce most-favored-nation (MFN) pricing by directing the Secretary of Health and Human ...

Following through on President Donald Trump’s “most favored nation” policy, the HHS is about to drop a drug pricing hammer on ...

President Donald Trump issued an executive order (EO) on May 12, 2025 to address the high cost of prescription drugs in the ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

President Trump has elevated an issue Democrats have been jawboning about for years. The president issued an executive order ...

Federal agencies are seeking public feedback on how to improve price transparency around prescription drugs and boost ...

A new State of Drug Access report shows that more than 40% of people living in the US could not afford their prescribed drugs ...

The Health Resources and Services Administration has overseen the 340B Drug Pricing Program since its creation in 1992. That ...

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...